Persistent blood DNA methylation changes one year after SARS-CoV-2 infection

Joseph Balnis1,2, Andy Madrid3, Kirk J Hogan4

  • 1Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, USA.

Clinical Epigenetics
|July 23, 2022
PubMed

Insights

DNA methylation changes in circulating leukocytes persist long after COVID-19 recovery. Researchers found 71 differentially methylated regions (DMRs) one year post-discharge, indicating lasting epigenetic alterations from SARS-CoV-2 infection.

Area of Science:

  • Epigenetics
  • Immunology
  • Virology

Background:

  • COVID-19 infection causes significant changes in circulating leukocyte DNA methylation.
  • The persistence of these epigenetic alterations after disease resolution is not well understood.

Purpose of the Study:

  • To investigate whether DNA methylation changes in circulating leukocytes persist one year after SARS-CoV-2 infection.
  • To identify specific differentially methylated regions (DMRs) that remain altered post-recovery.

Main Methods:

  • Epigenotyping of circulating leukocytes from fifteen participants previously hospitalized for SARS-CoV-2.
  • Comparison of DNA methylation profiles one year after discharge with acute illness profiles.
  • Identification and characterization of persistent differentially methylated regions (DMRs).

Main Results:

  • Seventy-one out of 1505 acute illness-induced DMRs persisted one year after SARS-CoV-2 infection.
  • These persistent DMRs involved an average of 7 serial CpG positions.
  • The majority of persistent DMRs (64) were hypermethylated, while 7 were hypomethylated.

Conclusions:

  • DNA methylation alterations in circulating leukocytes can endure long after recovery from acute SARS-CoV-2 infection.
  • These findings provide the first evidence of long-lasting epigenetic changes following COVID-19.
  • Persistent epigenetic modifications may contribute to long-term health consequences of COVID-19.